William Heisel
Contributing Editor
Contributing Editor
I have reported on health for most of my career. My work as an investigative reporter at the Los Angeles Times and the Orange County Register exposed problems with the fertility industry, the trade in human body parts and the use of illegal drugs in sports. I helped create a first-of-its-kind report card judging hospitals on a wide array of measures for a story that was a finalist for the Pulitzer Prize. I was one of the lead reporters on a series of stories about lead in candy, a series that also was a finalist for the Pulitzer.For the Center for Health Journalism (previously known as Reporting on Health), I have written about investigative health reporting and occasionally broke news on my column, Antidote. I also was the project editor on the Just One Breath collaborative reporting series. These days, for the University of Washington, I now work as the Executive Director for Insitutue for Health Metrics and Evaluation's Client Services, a social enterprise. You can follow me on Twitter @wheisel.
On Tuesday, the FDA announced that it will require the food industry to eliminate the use of artificial trans fats by 2018. Does that mean trans fats will soon disappear completely? Not quite. Here are five things to watch for as the FDA’s new ruling rolls out.
Requiring certain ingredients to be listed on food labels can often drive larger changes in what we consume. The U.S. required trans fats to appear on food labels in 2006, but countries such as Brazil and Argentina have gone much further in setting limits on the unhealthy fats.
Why have policies limiting the prevalence of trans fats been so slow to arrive? A brief history explains how policy actions aimed at curbing such fats, now known for their role in chronic diseases, ultimately gained traction in tip-of-the-spear countries such as Denmark.
Unhealthy trans fats have long remained a staple in our food supply, but that’s slowly starting to change. Denmark provides a useful case study for what happens when countries move to limit the amount of trans fats in food.
New research offers some much-need recommendations on how to curb MRSA infections among nursing home residents. As it turns out, the activities that pose the greatest risk of infection aren't always what you might think they'd be.
California is taking another run at requiring doctors to check a patient’s prescription history before prescribing potentially addictive drugs, with legislation passing the state senate yesterday. But will California legislators make the same kinds of compromises with providers that Oklahoma did?
Oklahoma is one of only a handful of states that require physicians to check a patient’s prescription history before prescribing potentially addictive drugs. How did Oklahoma enact this requirement when so many other states, such as California, have tried and failed?
In April, the governor of Oklahoma signed a bill that requires doctors to check a state-run database of patients and prescriptions before writing a new prescription for addictive medications. That makes the state a national leader in efforts to track such prescriptions and curtail abuse.
Organ transplants are increasing at a faster rate than the population in the U.S., but not all transplant programs are created equal. Knowing where to find the relevant data can help you dig deeper and explore regional variations in wait times and success rates.
'Tis the season for thousands of would-be doctors to line up in caps and gowns and receive their degrees before heading off to residency programs. These programs are accredited by ACGME, a group you should know about — lost accreditation can be a big story.